Risperidone versus haloperidol: I. meta-analysis of efficacy and safety-Reference-Cited by-同舟云学术

Risperidone versus haloperidol: I. meta-analysis of efficacy and safety

Published:1998-01 Issue:1 Volume:20 Page:58-71
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Davies Alison,Adena Michael A.,Keks Nicholas A.,Catts Stanley V.,Lambert Tim,Schweitzer Isaac

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference36 articles.

1. Pharmacology of risperidone (R64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonist properties;Janssen;J Pharmacol Exp Ther,1988

2. Biochemical profile of risperidone, a new antipsychotic;Leysen;J Pharmacol Exp Ther,1988

3. Mechanism of the antipsychotic effect in the treatment of acute schizophrenia;Johnstone;Lancet,1978

4. Risperidone compared with new and reference antipsychotic drugs—in vitro and in vivo receptor binding;Schotte;Psychopharmacology,1996

5. Risperidone versus haloperidol versus placebo in the treatment of schizophrenia;Borison,1991

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risperidone;Meyler's Side Effects of Drugs;2016

2. Neuroleptic drugs;Meyler's Side Effects of Drugs;2016

3. Weight Gain in Risperidone Therapy;Journal of Clinical Psychopharmacology;2013-10

4. A systematic review of meta-analyses of the efficacy of oral atypical antipsychotics for the treatment of adult patients with schizophrenia;Expert Opinion on Pharmacotherapy;2011-10-17

5. Very Low-Dose Risperidone in First-Episode Psychosis: A Safe and Effective Way to Initiate Treatment;Schizophrenia Research and Treatment;2011